Journal
CURRENT TOPICS IN MEDICINAL CHEMISTRY
Volume 10, Issue 8, Pages 828-858Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156802610791164238
Keywords
Endocannabinoids; Fatty acid amide hydrolase; Monoglyceride lipase; Monoacylglycerol lipase; N-arachidonoylethanolamine; 2-Arachidonoylglycerol
Categories
Funding
- Graduate School of Organic Chemistry and Chemical Biology (GSOCCB)
- Academy of Finland [110277]
- Association of Finnish Chemical Societies
- Academy of Finland (AKA) [110277, 110277] Funding Source: Academy of Finland (AKA)
Ask authors/readers for more resources
Fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL) are hydrolytic enzymes which degrade the endogenous cannabinoids (endocannabinoids) N-arachidonoylethanolamine (anandamide, AEA) and 2-arachidonoylglycerol (2-AG), respectively. Endocannabinoids are an important class of lipid messenger molecules that are produced on demand in response to elevated intracellular calcium levels. They recognize and activate the cannabinoid CB1 and CB2 receptors, the molecular targets for Delta(9)-tetrahydrocannabinol (Delta(9)-THC) in marijuana evoking several beneficial therapeutic effects. However, in vivo the cannabimimetic effects of AEA and 2-AG remain weak owing to their rapid inactivation by FAAH and MGL, respectively. The inactivation of FAAH and MGL by specific enzyme inhibitors increases the levels of AEA and 2-AG, respectively, producing therapeutic effects such as pain relief and depression of anxiety. A variety of chemically diverse FAAH and MGL inhibitors have been developed and synthesized recently. Thus, this article reviews the scientific literature of various FAAH and MGL inhibitors presented during the past ten years.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available